Biosimilars

The Pharmacy Times® Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy.

Latest News

Pharmacist gathering prescription medication
House Committee Hearing Addresses PBMs, Anticompetitive Drug Pricing Tactics

September 22nd 2023

The House Committee members examined pricing tactics by PBMs and how they are harming patients across the country.

Image credit: Sherry Young - stock.adobe.com
First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes

September 19th 2023

Image credit: lexiconimages - stock.adobe.com
The Promise of Biosimilars Is Within Reach for Health Systems

September 15th 2023

Designation of Interchangeability (IC) for Biosimilars in the US: To Be IC or Not IC? That Is the Question
Designation of Interchangeability (IC) for Biosimilars in the US: To Be IC or Not IC? That Is the Question

September 14th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.